Braxia Scientific Corp.

Braxia Scientific Corp.

Private Company
Public Company
Subsidiary of
Clinic Operator
Consumer Packaged Goods


Braxia Scientific is a research driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as major depressive disorder among others. Braxia Scientific is primarily focused on owning and operating multidisciplinary clinics providing treatment for mental health disorders and research activities related to discovering and commercializing novel drugs and delivery methods.

Braxia develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., currently operates multidisciplinary community-based clinics offering rapid-onset treatments for depression located in Mississauga, Toronto, Ottawa, and Montreal.